Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-022-29342-0
Download full text from publisher
References listed on IDEAS
- Matthew M. Gubin & Xiuli Zhang & Heiko Schuster & Etienne Caron & Jeffrey P. Ward & Takuro Noguchi & Yulia Ivanova & Jasreet Hundal & Cora D. Arthur & Willem-Jan Krebber & Gwenn E. Mulder & Mireille T, 2014. "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens," Nature, Nature, vol. 515(7528), pages 577-581, November.
- Elise Alspach & Danielle M. Lussier & Alexander P. Miceli & Ilya Kizhvatov & Michel DuPage & Adrienne M. Luoma & Wei Meng & Cheryl F. Lichti & Ekaterina Esaulova & Anthony N. Vomund & Daniele Runci & , 2019. "MHC-II neoantigens shape tumour immunity and response to immunotherapy," Nature, Nature, vol. 574(7780), pages 696-701, October.
- Alexander C. Huang & Michael A. Postow & Robert J. Orlowski & Rosemarie Mick & Bertram Bengsch & Sasikanth Manne & Wei Xu & Shannon Harmon & Josephine R. Giles & Brandon Wenz & Matthew Adamow & Debora, 2017. "T-cell invigoration to tumour burden ratio associated with anti-PD-1 response," Nature, Nature, vol. 545(7652), pages 60-65, May.
- Ricardo Romero-Moreno & Kimberly J. Curtis & Thomas R. Coughlin & Maria Cristina Miranda-Vergara & Shourik Dutta & Aishwarya Natarajan & Beth A. Facchine & Kristen M. Jackson & Lukas Nystrom & Jun Li , 2019. "The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis," Nature Communications, Nature, vol. 10(1), pages 1-14, December.
- Vinod P. Balachandran & Marta Łuksza & Julia N. Zhao & Vladimir Makarov & John Alec Moral & Romain Remark & Brian Herbst & Gokce Askan & Umesh Bhanot & Yasin Senbabaoglu & Daniel K. Wells & Charles Ia, 2017. "Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer," Nature, Nature, vol. 551(7681), pages 512-516, November.
- Paul C. Tumeh & Christina L. Harview & Jennifer H. Yearley & I. Peter Shintaku & Emma J. M. Taylor & Lidia Robert & Bartosz Chmielowski & Marko Spasic & Gina Henry & Voicu Ciobanu & Alisha N. West & M, 2014. "PD-1 blockade induces responses by inhibiting adaptive immune resistance," Nature, Nature, vol. 515(7528), pages 568-571, November.
- Se Jin Im & Masao Hashimoto & Michael Y. Gerner & Junghwa Lee & Haydn T. Kissick & Matheus C. Burger & Qiang Shan & J. Scott Hale & Judong Lee & Tahseen H. Nasti & Arlene H. Sharpe & Gordon J. Freeman, 2016. "Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy," Nature, Nature, vol. 537(7620), pages 417-421, September.
- Yannick Simoni & Etienne Becht & Michael Fehlings & Chiew Yee Loh & Si-Lin Koo & Karen Wei Weng Teng & Joe Poh Sheng Yeong & Rahul Nahar & Tong Zhang & Hassen Kared & Kaibo Duan & Nicholas Ang & Micha, 2018. "Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates," Nature, Nature, vol. 557(7706), pages 575-579, May.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Elaine Lai-Han Leung & Run-Ze Li & Xing-Xing Fan & Lily Yan Wang & Yan Wang & Zebo Jiang & Jumin Huang & Hu-Dan Pan & Yue Fan & Hongmei Xu & Feng Wang & Haopeng Rui & Piu Wong & Hermi Sumatoh & Michae, 2023. "Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
- John P. Finnigan & Jenna H. Newman & Yury Patskovsky & Larysa Patskovska & Andrew S. Ishizuka & Geoffrey M. Lynn & Robert A. Seder & Michelle Krogsgaard & Nina Bhardwaj, 2024. "Structural basis for self-discrimination by neoantigen-specific TCRs," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Meghana Pagadala & Timothy J. Sears & Victoria H. Wu & Eva Pérez-Guijarro & Hyo Kim & Andrea Castro & James V. Talwar & Cristian Gonzalez-Colin & Steven Cao & Benjamin J. Schmiedel & Shervin Goudarzi , 2023. "Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
- Jani Huuhtanen & Liang Chen & Emmi Jokinen & Henna Kasanen & Tapio Lönnberg & Anna Kreutzman & Katriina Peltola & Micaela Hernberg & Chunlin Wang & Cassian Yee & Harri Lähdesmäki & Mark M. Davis & Sat, 2022. "Evolution and modulation of antigen-specific T cell responses in melanoma patients," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
- Kenro Tanoue & Hirofumi Ohmura & Koki Uehara & Mamoru Ito & Kyoko Yamaguchi & Kenji Tsuchihashi & Yudai Shinohara & Peng Lu & Shingo Tamura & Hozumi Shimokawa & Taichi Isobe & Hiroshi Ariyama & Yoshih, 2024. "Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Zhen Zeng & Tianbei Zhang & Jiajia Zhang & Shuai Li & Sydney Connor & Boyang Zhang & Yimin Zhao & Jordan Wilson & Dipika Singh & Rima Kulikauskas & Candice D. Church & Thomas H. Pulliam & Saumya Jani , 2025. "A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
- Qing Li & Hao Zeng & Ting Liu & Peipei Wang & Rui Zhang & Binyan Zhao & Tang Feng & Yuling Yang & Jiumei Wu & Yue Zheng & Bailing Zhou & Yang Shu & Heng Xu & Li Yang & Zhenyu Ding, 2024. "A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
- Thomas Kuilman & Deborah S. Schrikkema & Jules Gadiot & Raquel Gomez-Eerland & Laura Bies & Julia Walker & Robbert M. Spaapen & Hanna Kok & Demi Houg & Milena Viyacheva & Yvonne B. Claassen & Manuel S, 2025. "Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies," Nature Communications, Nature, vol. 16(1), pages 1-14, December.
- Sara Orehek & Taja Železnik Ramuta & Duško Lainšček & Špela Malenšek & Martin Šala & Mojca Benčina & Roman Jerala & Iva Hafner-Bratkovič, 2024. "Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
- Chunping Mao & Fuan Deng & Wanning Zhu & Leiming Xie & Yijun Wang & Guoyin Li & Xingke Huang & Jiahui Wang & Yue Song & Ping Zeng & Zhenpeng He & Jingnan Guo & Yao Suo & Yujing Liu & Zhuo Chen & Mingx, 2024. "In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
- Jianjiao Ni & Xiaofei Wang & Lin Wu & Xinghao Ai & Qian Chu & Chengbo Han & Xiaorong Dong & Yue Zhou & Yechun Pang & Zhengfei Zhu, 2024. "Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
- Teresa Maria Rosaria Noviello & Anna Maria Giacomo & Francesca Pia Caruso & Alessia Covre & Roberta Mortarini & Giovanni Scala & Maria Claudia Costa & Sandra Coral & Wolf H. Fridman & Catherine Sautès, 2023. "Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
- Yu Feng & Wenjuan Ma & Yupeng Zang & Yanying Guo & Young Li & Yixuan Zhang & Xuan Dong & Yi Liu & Xiaojuan Zhan & Zhizhong Pan & Mei Luo & Miaoqing Wu & Ao Chen & Da Kang & Gong Chen & Longqi Liu & Ji, 2024. "Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Laura Y. Zhou & Fei Zou & Wei Sun, 2023. "Prioritizing candidate peptides for cancer vaccines through predicting peptide presentation by HLA‐I proteins," Biometrics, The International Biometric Society, vol. 79(3), pages 2664-2676, September.
- Zhigui Zuo & Hao Yin & Yu Zhang & Congying Xie & Qinyang Wang, 2023. "A cytotoxic T cell inspired oncolytic nanosystem promotes lytic cell death by lipid peroxidation and elicits antitumor immune responses," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
- Zhenlin Yang & He Tian & Xiaowei Chen & Bozhao Li & Guangyu Bai & Qingyuan Cai & Jiachen Xu & Wei Guo & Shuaibo Wang & Yue Peng & Qing Liang & Liyan Xue & Shugeng Gao, 2024. "Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Judit Svensson-Arvelund & Sara Cuadrado-Castano & Gvantsa Pantsulaia & Kristy Kim & Mark Aleynick & Linda Hammerich & Ranjan Upadhyay & Michael Yellin & Henry Marsh & Daniel Oreper & Suchit Jhunjhunwa, 2022. "Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Rana Falahat & Anders Berglund & Patricio Perez-Villarroel & Ryan M. Putney & Imene Hamaidi & Sungjune Kim & Shari Pilon-Thomas & Glen N. Barber & James J. Mulé, 2023. "Epigenetic state determines the in vivo efficacy of STING agonist therapy," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
- Emily N. Neubert & Julia M. DeRogatis & Sloan A. Lewis & Karla M. Viramontes & Pedro Ortega & Monique L. Henriquez & Rémi Buisson & Ilhem Messaoudi & Roberto Tinoco, 2023. "HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
- Yumin Wu & Bo Liu & Yifan Yan & Chuntao Gong & Kaiwei Wang & Nanhui Liu & Yujie Zhu & Maoyi Li & Chunjie Wang & Yizhe Yang & Liangzhu Feng & Zhuang Liu, 2024. "Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-29342-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.